Myriad Genetics Inc. Earnings

Myriad Genetics Inc.’s revenue jumped 7.12% since last year same period to $210.6Mn in the Q4 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated -1.27% fall in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit fell -36.22% since last year same period to $-42.5Mn in the Q4 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated -92.31% fall in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin fell -27.16% since last year same period to -20.18% in the Q4 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated -94.77% fall in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.03 - a 51.5% jump from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at 0.03.

Myriad Genetics Inc.’s earning per share (EPS) fell -25% since last year same period to 0.03 in the Q4 2024. This indicates that the Myriad Genetics Inc. has generated -25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.